Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-233369
Filing Date
2026-05-21
Accepted
2026-05-21 08:51:44
Documents
4
Period of Report
2026-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d38874ddef14a.htm DEF 14A 347421
2 GRAPHIC g38874g02g02.jpg GRAPHIC 48575
3 GRAPHIC g38874g08e08.jpg GRAPHIC 212642
4 GRAPHIC g38874g09e09.jpg GRAPHIC 198568
  Complete submission text file 0001193125-26-233369.txt   980513
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38327 | Film No.: 261006064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)